$221 Million is the total value of KNOTT DAVID M's 145 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 32.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LGND | Ligand Pharmaceuticals Incorporated | $24,667,000 | +4.3% | 248,041 | 0.0% | 11.16% | -19.5% | |
UPLD | Upland Software, Inc. | $18,654,000 | +21.7% | 406,500 | 0.0% | 8.44% | -6.1% | |
FTAI | Fortress Trans & Infrastructure Inv. LLC | $16,422,000 | +37.0% | 700,000 | 0.0% | 7.43% | +5.6% | |
APO | Apollo Global Management, Inc. | $14,694,000 | +9.5% | 300,000 | 0.0% | 6.65% | -15.6% | |
DNMR | New | Danimer Scientific, Inc. | $11,755,000 | – | 500,000 | +100.0% | 5.32% | – |
GOOG | Alphabet Inc-Cl C | $9,811,000 | +19.2% | 5,600 | 0.0% | 4.44% | -8.1% | |
CLMT | Buy | Calumet Specialty Products Partners, LP | $8,279,000 | +60.7% | 2,645,000 | +30.9% | 3.75% | +24.0% |
MDWT | Buy | Midwest Holdings Inc. | $7,705,000 | +517.9% | 143,621 | +72.3% | 3.49% | +376.4% |
FSK | New | FS KKR Capital Corp. | $6,544,000 | – | 395,175 | +100.0% | 2.96% | – |
PFE | Sell | Pfizer Inc. | $4,413,000 | -8.8% | 119,900 | -9.1% | 2.00% | -29.7% |
LKQ | Sell | LKQ Corporation | $4,229,000 | +1.7% | 120,000 | -20.0% | 1.91% | -21.6% |
KKR | KKR & Co. Inc. | $4,049,000 | +17.9% | 100,000 | 0.0% | 1.83% | -9.1% | |
GILD | Buy | Gilead Sciences, Inc. | $3,778,000 | +443.6% | 64,842 | +489.5% | 1.71% | +319.1% |
KW | Kennedy-Wilson Holdings, Inc. | $3,757,000 | +23.2% | 210,000 | 0.0% | 1.70% | -5.0% | |
EIGR | Buy | Eiger BioPharmaceuticals, Inc. | $3,626,000 | +61.8% | 295,035 | +7.1% | 1.64% | +24.8% |
ABBV | Sell | AbbVie Inc. | $3,511,000 | +6.1% | 32,769 | -13.2% | 1.59% | -18.1% |
VXX | New | iPath Series B S&P 500 VIX Short-Term Fut | $3,358,000 | – | 200,000 | +100.0% | 1.52% | – |
EBC | New | Eastern Bankshares Inc | $3,262,000 | – | 200,000 | +100.0% | 1.48% | – |
BMY | Buy | Bristol-Myers Squibb Company | $3,251,000 | +16.2% | 52,409 | +12.9% | 1.47% | -10.4% |
HZNP | Buy | Horizon Therapeutics Public Ltd. Company | $3,117,000 | +6.9% | 42,614 | +13.5% | 1.41% | -17.5% |
XENE | Buy | Xenon Pharmaceuticals Inc. | $3,076,000 | +57.0% | 200,000 | +13.0% | 1.39% | +21.1% |
KDMN | Buy | Kadmon Holdings, Inc. | $2,913,000 | +21.4% | 702,000 | +14.7% | 1.32% | -6.4% |
TGTX | TG Therapeutics Inc. | $2,641,000 | +94.3% | 50,773 | 0.0% | 1.20% | +49.9% | |
CAPU | New | Capitol Investment Corp. V | $2,575,000 | – | 250,000 | +100.0% | 1.16% | – |
Sell | Trillium Therapeutics Inc. | $2,570,000 | +2.6% | 174,699 | -0.9% | 1.16% | -20.8% | |
JPM | Sell | JP Morgan Chase | $2,538,000 | +14.4% | 19,970 | -13.4% | 1.15% | -11.8% |
AUPH | Buy | Aurinia Pharmaceuticals Inc. | $2,455,000 | +23.8% | 177,540 | +31.9% | 1.11% | -4.5% |
ZGNX | Zogenix, Inc. | $2,253,000 | +11.5% | 112,707 | 0.0% | 1.02% | -14.0% | |
MPLX | MPLX LP | $2,165,000 | +37.5% | 100,000 | 0.0% | 0.98% | +6.2% | |
HZAC | New | Horizon Aquistion Corporation | $2,105,000 | – | 210,100 | +100.0% | 0.95% | – |
RTP | New | Reinvent Technology Partners | $2,037,000 | – | 176,226 | +100.0% | 0.92% | – |
IGT | International Gaming Technologies | $1,821,000 | +52.3% | 107,500 | 0.0% | 0.82% | +17.4% | |
CHRS | Buy | Coherus Biosciences, Inc. | $1,767,000 | -3.2% | 101,655 | +2.2% | 0.80% | -25.3% |
AB | AllianceBernstein Holding PL Unit Ltd. | $1,706,000 | +24.9% | 50,500 | 0.0% | 0.77% | -3.6% | |
ALXN | Sell | Alexion Pharamaceuticals, Inc. | $1,648,000 | +20.0% | 10,545 | -12.1% | 0.75% | -7.4% |
BCRX | Sell | BioCryst Pharmaceuticals, Inc. | $1,635,000 | +19.8% | 219,461 | -44.8% | 0.74% | -7.6% |
BDSI | Sell | BioDelivery Sciences International, Inc. | $1,555,000 | -13.5% | 370,230 | -23.2% | 0.70% | -33.3% |
VAPO | Vapotherm, Inc. | $1,316,000 | -7.4% | 49,000 | 0.0% | 0.60% | -28.5% | |
QURE | Buy | uniQure N.V. | $1,265,000 | +10.8% | 35,000 | +12.9% | 0.57% | -14.6% |
VKTX | Viking Therapeutics, Inc. | $1,228,000 | -3.2% | 218,102 | 0.0% | 0.56% | -25.4% | |
VZ | Verizon Communications | $1,076,000 | -1.3% | 18,311 | 0.0% | 0.49% | -23.9% | |
JNJ | Sell | Johnson & Johnson | $956,000 | -11.8% | 6,080 | -16.5% | 0.43% | -31.9% |
CNST | New | Constellation Phamaceuticals, Inc. | $950,000 | – | 33,000 | +100.0% | 0.43% | – |
MDLZ | Mondelez Int'l Inc. | $930,000 | +1.8% | 15,900 | 0.0% | 0.42% | -21.5% | |
VRCA | Buy | Verrica Pharmaceuticals, Inc. | $881,000 | +146.8% | 76,585 | +66.0% | 0.40% | +90.9% |
DD | Dupont De Nemours Inc. | $861,000 | +28.1% | 12,118 | 0.0% | 0.39% | -1.0% | |
RHP | Ryman Hospitality Ppty Inc. | $840,000 | +83.8% | 12,400 | 0.0% | 0.38% | +41.8% | |
CDTX | Buy | Cidara Therapeutics, Inc. | $831,000 | -28.4% | 415,308 | +2.0% | 0.38% | -44.8% |
KMB | Kimberly Clark Corporation | $809,000 | -8.7% | 6,000 | 0.0% | 0.37% | -29.6% | |
KO | Coca Cola | $735,000 | +11.2% | 13,400 | 0.0% | 0.33% | -14.2% | |
DOW | Dow Inc. | $673,000 | +18.1% | 12,118 | 0.0% | 0.30% | -8.7% | |
New | Strongbridge Biopharma PLC | $647,000 | – | 266,194 | +100.0% | 0.29% | – | |
T | AT&T Inc. | $634,000 | +1.0% | 22,050 | 0.0% | 0.29% | -22.0% | |
AVDL | New | Avadel Pharmaceuticals plc | $581,000 | – | 86,916 | +100.0% | 0.26% | – |
IBM | International Business Machines | $539,000 | +3.5% | 4,284 | 0.0% | 0.24% | -20.3% | |
CNQ | Sell | Canadian Natural Resources Inc. | $536,000 | +4.5% | 22,285 | -30.4% | 0.24% | -19.3% |
MIC | Macquarie Infrastructure Corporation | $494,000 | +39.5% | 13,150 | 0.0% | 0.22% | +7.7% | |
CTVA | Corveta Inc. | $486,000 | +34.6% | 12,545 | 0.0% | 0.22% | +3.8% | |
QUOT | New | Quotient Technology Inc. | $471,000 | – | 50,000 | +100.0% | 0.21% | – |
RDUS | Sell | Radius Health Inc. | $447,000 | -18.0% | 25,034 | -47.9% | 0.20% | -36.9% |
WPC | WP Carey | $423,000 | +8.2% | 6,000 | 0.0% | 0.19% | -16.6% | |
EDIT | New | Editas Medicine Inc. | $421,000 | – | 6,000 | +100.0% | 0.19% | – |
FGEN | Sell | FibroGen, Inc. | $371,000 | -54.3% | 10,000 | -49.3% | 0.17% | -64.7% |
LGVW | New | Longview Aquisition Corp. | $364,000 | – | 18,380 | +100.0% | 0.16% | – |
CAG | Conagra Brands | $363,000 | +1.7% | 10,000 | 0.0% | 0.16% | -21.5% | |
TARA | Buy | Protara Therapeutics, Inc. | $348,000 | +159.7% | 14,369 | +80.8% | 0.16% | +98.7% |
New | Alimera Sciences, Inc. | $338,000 | – | 80,194 | +100.0% | 0.15% | – | |
MSFT | Microsoft Corporation | $311,000 | +5.8% | 1,400 | 0.0% | 0.14% | -18.0% | |
New | Marinus Pharmaceutical, Inc. | $305,000 | – | 25,000 | +100.0% | 0.14% | – | |
GMED | Buy | Globus Medical, Inc. | $302,000 | +109.7% | 4,631 | +59.7% | 0.14% | +63.1% |
AAPL | Sell | Apple Inc. | $279,000 | -42.6% | 2,100 | -50.0% | 0.13% | -55.8% |
ALXO | Buy | ALX Oncology. Inc | $276,000 | +144.2% | 3,200 | +6.7% | 0.12% | +89.4% |
FSBW | FS Bancorp | $196,000 | +33.3% | 3,577 | 0.0% | 0.09% | +3.5% | |
IBB | iShares Nasdaq Biotechnology ETF | $151,000 | +11.9% | 1,000 | 0.0% | 0.07% | -13.9% | |
SSB | South Street Corporation | $151,000 | +49.5% | 2,082 | 0.0% | 0.07% | +15.3% | |
KHC | The Kraft Heinz Company | $147,000 | +15.7% | 4,234 | 0.0% | 0.07% | -10.7% | |
LEGH | Legacy Housing Corporation | $136,000 | +10.6% | 9,000 | 0.0% | 0.06% | -13.9% | |
MDT | Medtronics | $123,000 | +12.8% | 1,050 | 0.0% | 0.06% | -12.5% | |
VLY | Valley National Bancorp | $121,000 | +40.7% | 12,480 | 0.0% | 0.06% | +10.0% | |
TTE | Total SA | $120,000 | +22.4% | 2,860 | 0.0% | 0.05% | -5.3% | |
CUZ | Cousins Properties | $112,000 | +16.7% | 3,357 | 0.0% | 0.05% | -8.9% | |
HRGG | Heritage NOLA Bancorp Inc. | $110,000 | +13.4% | 9,000 | 0.0% | 0.05% | -12.3% | |
AXGT | New | Axovant Gene Therapeutic, Ltd | $111,000 | – | 40,000 | +100.0% | 0.05% | – |
Merck & Co. Inc. | $106,000 | -0.9% | 1,300 | 0.0% | 0.05% | -23.8% | ||
RLMD | Relmada Therapeutics, Inc. | $96,000 | -15.0% | 3,000 | 0.0% | 0.04% | -34.8% | |
FNB | FNB Corporation | $85,000 | +41.7% | 8,905 | 0.0% | 0.04% | +8.6% | |
CFFN | Capitol Federal S&L | $73,000 | +35.2% | 5,800 | 0.0% | 0.03% | +3.1% | |
CTIC | New | CTI BioPharma Corp. | $64,000 | – | 20,000 | +100.0% | 0.03% | – |
GE | General Electric | $51,000 | +75.9% | 4,680 | 0.0% | 0.02% | +35.3% | |
OXY | Occidental Pete Corp | $51,000 | +70.0% | 2,973 | 0.0% | 0.02% | +27.8% | |
LLY | Eli Lilly Inc. | $51,000 | +15.9% | 300 | 0.0% | 0.02% | -11.5% | |
BMYRT | Buy | Bristol-Myers Squibb Company - CVR | $45,000 | +275.0% | 64,720 | +1144.6% | 0.02% | +185.7% |
ADMA | Sell | ADMA Biologics, Inc. | $42,000 | -73.1% | 21,457 | -67.1% | 0.02% | -79.3% |
CC | Chemours Co. | $29,000 | +20.8% | 1,160 | 0.0% | 0.01% | -7.1% | |
ACIU | AC Immune SA | $27,000 | +3.8% | 5,309 | 0.0% | 0.01% | -20.0% | |
EXP | Eagle Materials | $23,000 | +15.0% | 228 | 0.0% | 0.01% | -16.7% | |
LPTX | New | Leap Therapeutics, Inc. | $22,000 | – | 9,700 | +100.0% | 0.01% | – |
BNS | Bank Nova Scotia Halifax | $22,000 | +29.4% | 400 | 0.0% | 0.01% | 0.0% | |
PBCT | Peoples United Financial | $19,000 | +26.7% | 1,500 | 0.0% | 0.01% | 0.0% | |
DFPHU | New | DFP Healthcare Acquistions Corp. | $11,000 | – | 1,000 | +100.0% | 0.01% | – |
SVC | Service Ppty Trust | $11,000 | +37.5% | 1,000 | 0.0% | 0.01% | 0.0% | |
OXYWS | Occidental Pete Corp Wts exp 8/3/27 | $8,000 | – | 370 | 0.0% | 0.00% | – | |
STWD | Starwood Ppty | $8,000 | +33.3% | 400 | 0.0% | 0.00% | 0.0% | |
CLNY | Colony Cap Inc. | $7,000 | +75.0% | 1,466 | 0.0% | 0.00% | +50.0% | |
VTRS | New | Viatris Inc. | $5,000 | – | 80 | +100.0% | 0.00% | – |
AMLP | Alerian MLP | $3,000 | +50.0% | 120 | 0.0% | 0.00% | 0.0% | |
SCU | Sculptor Capital Management | $3,000 | +50.0% | 200 | 0.0% | 0.00% | 0.0% | |
WAB | WABTEC | $1,000 | 0.0% | 23 | 0.0% | 0.00% | -100.0% | |
CHEK | Check Cap Ltd. | $1,000 | 0.0% | 2,224 | 0.0% | 0.00% | -100.0% | |
RMR | RMR Group Inc. | $1,000 | – | 16 | 0.0% | 0.00% | – | |
CRDF | Exit | Cardiff Oncology, Inc. | $0 | – | -5,000 | -100.0% | -0.04% | – |
KRYS | Exit | Krystal Biotech, Inc. | $0 | – | -7,079 | -100.0% | -0.18% | – |
CYTK | Exit | Cytokinetics, Incorporated | $0 | – | -15,837 | -100.0% | -0.20% | – |
CCXI | Exit | ChemoCentryx, Inc. | $0 | – | -6,587 | -100.0% | -0.21% | – |
ALIM | Exit | Alimera Sciences, Inc. | $0 | – | -80,194 | -100.0% | -0.23% | – |
COLL | Exit | Collegium Pharmaceutical, Inc. | $0 | – | -29,862 | -100.0% | -0.36% | – |
ALKS | Exit | Alkermes PLC | $0 | – | -38,000 | -100.0% | -0.37% | – |
SBBP | Exit | Strongbridge Biopharma PLC | $0 | – | -372,000 | -100.0% | -0.46% | – |
FSK | Exit | FS KKR Capital Corp. | $0 | – | -395,175 | -100.0% | -3.68% | – |
SRCL | Exit | Stericycle, Inc. | $0 | – | -160,000 | -100.0% | -5.92% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Ligand Pharmaceuticals Incorporated | 34 | Q3 2021 | 52.6% |
Pfizer Inc. | 34 | Q3 2021 | 17.4% |
Capitol Federal S&L | 34 | Q3 2021 | 5.7% |
JP Morgan Chase& Co. | 34 | Q3 2021 | 1.3% |
Apple Inc. | 34 | Q3 2021 | 2.1% |
Microsoft Corporation | 34 | Q3 2021 | 2.3% |
AllianceBernstein Holdings PL Unit Ltd. | 34 | Q3 2021 | 0.9% |
Johnson & Johnson | 34 | Q3 2021 | 0.6% |
Mondelez Int'lt Inc. | 34 | Q3 2021 | 0.5% |
Ryman Hospitality PPTYS Inc. | 34 | Q3 2021 | 0.4% |
View KNOTT DAVID M's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
LIGAND PHARMACEUTICALS INC | February 13, 2018 | 865,500 | 4.1% |
Rand Logistics, Inc. | November 15, 2017 | 1,432,660 | 7.2% |
Essex Rental Corp. | August 16, 2013 | 1,124,472 | 4.5% |
Westway Group, Inc. | February 01, 2013 | ? | ? |
FutureFuel Corp. | February 01, 2012 | 1,838,000 | 4.5% |
COLUMBIA LABORATORIES INC | January 31, 2012 | ? | ? |
Essex Rental Corp. | February 16, 2011 | 2,805,666 | 13.0% |
Pet DRx CORPSold out | February 09, 2011 | 0 | 0.0% |
China Ceramics Co., Ltd | October 14, 2010 | 1,350,000 | 10.3% |
NABI BIOPHARMACEUTICALS | June 22, 2010 | 2,344,597 | 4.8% |
View KNOTT DAVID M's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2021-11-12 |
13F-HR | 2021-08-13 |
13F-HR | 2021-05-13 |
13F-HR | 2021-02-12 |
13F-HR | 2020-11-13 |
13F-HR | 2020-08-12 |
13F-HR | 2020-05-13 |
13F-HR | 2020-02-14 |
13F-HR | 2019-11-12 |
13F-HR | 2019-08-12 |
View KNOTT DAVID M's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.